Recombinant human activated protein C, package labeling, and hemorrhage risks
- PMID: 19112285
- DOI: 10.1097/CCM.0b013e3181935102
Recombinant human activated protein C, package labeling, and hemorrhage risks
Comment in
-
Recombinant activated protein C and risk of bleeding.Crit Care Med. 2009 Jun;37(6):2140-1; author reply 2142. doi: 10.1097/CCM.0b013e3181a5c372. Crit Care Med. 2009. PMID: 19448480 No abstract available.
Comment on
-
Adverse outcomes associated with the use of drotrecogin alfa (activated) in patients with severe sepsis and baseline bleeding precautions.Crit Care Med. 2009 Jan;37(1):19-25. doi: 10.1097/CCM.0b013e318192843b. Crit Care Med. 2009. PMID: 19050637
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical